CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 67,907,092
- Share change
- +3,157,729
- Total reported value
- $201,992,589
- Put/Call ratio
- 59%
- Price per share
- $2.97
- Number of holders
- 140
- Value change
- +$603,491
- Number of buys
- 66
- Number of sells
- 70
Quarterly Holders Quick Answers
What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14888U101:
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2020
As of 30 Sep 2020,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,907,092 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, MANGROVE PARTNERS, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, PRUDENTIAL FINANCIAL INC, ROYCE & ASSOCIATES LP, and LSV ASSET MANAGEMENT.
This page lists
140
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
138
Q3 2020 holders
140
Holder diff
2
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.